VSM Wealth Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Hold
92
0.01% 300
2026
Q1
$16.9K Hold
92
0.01% 312
2025
Q4
$16.2K Hold
92
﹤0.01% 285
2025
Q3
$12.9K Hold
92
﹤0.01% 320
2025
Q2
$11.6K Hold
92
﹤0.01% 364
2025
Q1
$12.6K Buy
+92
New +$13.2K ﹤0.01% 326

Other funds holding BIIB

VSM Wealth Advisory's BIIB Position: Q2 2026 in Review

VSM Wealth Advisory held its Biogen (BIIB) position steady in Q2 2026 at 92 shares worth $19.9K. The position accounts for 0.01% of the portfolio, ranked #300.

VSM Wealth Advisory first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • VSM Wealth Advisory held 92 shares of Biogen worth $19.9K as of Q2 2026.
  • VSM Wealth Advisory left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of VSM Wealth Advisory's portfolio in Q2 2026, its #300 holding.
  • VSM Wealth Advisory first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.